AU2633199A - Anti-angiogenic vaccines: substances and methods relating thereto - Google Patents

Anti-angiogenic vaccines: substances and methods relating thereto

Info

Publication number
AU2633199A
AU2633199A AU26331/99A AU2633199A AU2633199A AU 2633199 A AU2633199 A AU 2633199A AU 26331/99 A AU26331/99 A AU 26331/99A AU 2633199 A AU2633199 A AU 2633199A AU 2633199 A AU2633199 A AU 2633199A
Authority
AU
Australia
Prior art keywords
angiogenic
vaccines
substances
methods relating
relating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26331/99A
Other languages
English (en)
Inventor
Linda Gillian Durrant
Peter William Hewett
Judith Margaret Ramage
Ian Spendlove
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cancer Research Campaign Technology Ltd
Original Assignee
Cancer Research Campaign Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Research Campaign Technology Ltd filed Critical Cancer Research Campaign Technology Ltd
Publication of AU2633199A publication Critical patent/AU2633199A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU26331/99A 1998-02-26 1999-02-26 Anti-angiogenic vaccines: substances and methods relating thereto Abandoned AU2633199A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9804121 1998-02-26
GBGB9804121.3A GB9804121D0 (en) 1998-02-26 1998-02-26 Anti-angiogenic vaccines: materials and methods relating thereto
PCT/GB1999/000583 WO1999043801A1 (en) 1998-02-26 1999-02-26 Anti-angiogenic vaccines: substances and methods relating thereto

Publications (1)

Publication Number Publication Date
AU2633199A true AU2633199A (en) 1999-09-15

Family

ID=10827659

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26331/99A Abandoned AU2633199A (en) 1998-02-26 1999-02-26 Anti-angiogenic vaccines: substances and methods relating thereto

Country Status (4)

Country Link
EP (1) EP1056852A1 (de)
AU (1) AU2633199A (de)
GB (1) GB9804121D0 (de)
WO (1) WO1999043801A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6521424B2 (en) 1999-06-07 2003-02-18 Immunex Corporation Recombinant expression of Tek antagonists
NZ523882A (en) 2000-08-21 2004-11-26 Pacific Corp Novel thiourea derivatives and the pharmaceutical compositions containing the same
WO2002069907A2 (en) 2001-03-07 2002-09-12 Mannkind Corporation Anti-neovasculature preparations for cancer
US7658924B2 (en) 2001-10-11 2010-02-09 Amgen Inc. Angiopoietin-2 specific binding agents
US7138370B2 (en) 2001-10-11 2006-11-21 Amgen Inc. Specific binding agents of human angiopoietin-2
US7521053B2 (en) 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
US7205275B2 (en) 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
EP2267023B1 (de) * 2002-09-12 2015-02-11 Oncotherapy Science, Inc. KDR-Peptide und diese enthaltende Impfstoffe
US20050118186A1 (en) 2003-06-17 2005-06-02 Chih-Sheng Chiang Combinations of tumor-associated antigens in compositions for various types of cancers
AU2005321898B2 (en) 2004-12-29 2012-07-19 Mannkind Corporation Use of compositions comprising various tumor-associated antigens as anti-cancer vaccines
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
JO2913B1 (en) 2008-02-20 2015-09-15 امجين إنك, Antibodies directed towards angiopoietin-1 and angiopoietin-2 proteins and their uses
TW201109029A (en) 2009-06-11 2011-03-16 Oncotherapy Science Inc Vaccine therapy for choroidal neovascularization

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4651893A (en) * 1992-06-26 1994-01-24 Immunex Corporation Novel tyrosine kinase
US5681714A (en) * 1992-07-30 1997-10-28 Mount Sinai Hospital Corporation Nucleic acid encoding tek receptor tyrosine kinase
WO1995013387A1 (en) * 1993-11-12 1995-05-18 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Tie-2, a novel receptor tyrosine kinase
AUPM379494A0 (en) * 1994-02-10 1994-03-03 Ludwig Institute For Cancer Research Immunointeractive molecules - ii
DE69723434T2 (de) * 1996-04-26 2004-05-19 Rijksuniversiteit Te Leiden Verfahren zur selektion und produktion von t-zell-peptide epitope und vakzine mit diese epitope

Also Published As

Publication number Publication date
GB9804121D0 (en) 1998-04-22
WO1999043801A1 (en) 1999-09-02
EP1056852A1 (de) 2000-12-06

Similar Documents

Publication Publication Date Title
AU2001227586A1 (en) Application report and method for creating the same
AU1458300A (en) Simultaneous cleaning and decontaminating compositions and methods
AU7989400A (en) Compounds and methods
AU3215500A (en) Compounds and methods
AU2001280599A1 (en) Compounds and methods
AU2001253418A1 (en) Compounds and methods
AU6064100A (en) Well-perforating and/or packing apparatus and method
AU2001286589A1 (en) Surface preparation agent and surface preparation method
AU2002213227A1 (en) Generalizer system and method
AU2001243394A1 (en) Compounds and methods
AU8230898A (en) Anti-bacterial methods and materials
GB9804121D0 (en) Anti-angiogenic vaccines: materials and methods relating thereto
AUPQ872300A0 (en) Compounds and methods
AU2001293118A1 (en) Dosimeter and method for using the same
AU2001274740A1 (en) High density products and method for the preparation thereof
AU2001233932A1 (en) Method and composition
AU1083501A (en) Antibiotic-metal complex and methods
AU1064800A (en) Products and methods
AU2001278951A1 (en) Compounds and methods
AU2002235277A1 (en) Compounds and methods
AU2002239775A1 (en) Chemical-library composition and method
AU2980799A (en) Lectomedin materials and methods
AU2002256556A1 (en) Sea-trosy and related methods
AU2002227019A1 (en) Cashcalling and voicemining system
AU2002223166A1 (en) Analytic method and reagent for use thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase